FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q96121778> ?p ?o ?g. }

• Q96121778 description "2020 nî lūn-bûn" @default.
• Q96121778 description "2020年の論文" @default.
• Q96121778 description "2020年学术文章" @default.
• Q96121778 description "2020年学术文章" @default.
• Q96121778 description "2020年学术文章" @default.
• Q96121778 description "2020年学术文章" @default.
• Q96121778 description "2020年学术文章" @default.
• Q96121778 description "2020年学术文章" @default.
• Q96121778 description "2020年學術文章" @default.
• Q96121778 description "2020年學術文章" @default.
• Q96121778 description "2020年學術文章" @default.
• Q96121778 description "2020年學術文章" @default.
• Q96121778 description "2020年學術文章" @default.
• Q96121778 description "2020년 논문" @default.
• Q96121778 description "article científic" @default.
• Q96121778 description "article scientific" @default.
• Q96121778 description "article scientifique" @default.
• Q96121778 description "articol științific" @default.
• Q96121778 description "articolo scientifico" @default.
• Q96121778 description "artigo científico" @default.
• Q96121778 description "artigo científico" @default.
• Q96121778 description "artigo científico" @default.
• Q96121778 description "artikel ilmiah" @default.
• Q96121778 description "artikull shkencor" @default.
• Q96121778 description "artikulong pang-agham" @default.
• Q96121778 description "artykuł naukowy" @default.
• Q96121778 description "artículo científico publicado en 2020" @default.
• Q96121778 description "artículu científicu" @default.
• Q96121778 description "bilimsel makale" @default.
• Q96121778 description "bài báo khoa học" @default.
• Q96121778 description "naučni članak" @default.
• Q96121778 description "scienca artikolo" @default.
• Q96121778 description "scientific article published in June 2020" @default.
• Q96121778 description "scientific article published in June 2020" @default.
• Q96121778 description "scientific article published on 01 June 2020" @default.
• Q96121778 description "teaduslik artikkel" @default.
• Q96121778 description "tieteellinen artikkeli" @default.
• Q96121778 description "tudományos cikk" @default.
• Q96121778 description "vedecký článok" @default.
• Q96121778 description "vetenskaplig artikel" @default.
• Q96121778 description "videnskabelig artikel udgivet juni 2020" @default.
• Q96121778 description "vitenskapelig artikkel" @default.
• Q96121778 description "vitskapeleg artikkel" @default.
• Q96121778 description "vědecký článek" @default.
• Q96121778 description "wetenschappelijk artikel" @default.
• Q96121778 description "wissenschaftlicher Artikel" @default.
• Q96121778 description "επιστημονικό άρθρο" @default.
• Q96121778 description "мақолаи илмӣ" @default.
• Q96121778 description "наукова стаття, опублікована в червні 2020" @default.
• Q96121778 description "научна статия" @default.
• Q96121778 description "научная статья" @default.
• Q96121778 description "научни чланак" @default.
• Q96121778 description "научни чланак" @default.
• Q96121778 description "מאמר מדעי" @default.
• Q96121778 description "مقالة علمية نشرت في يونيو 2020" @default.
• Q96121778 description "জুন ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q96121778 description "บทความทางวิทยาศาสตร์" @default.
• Q96121778 description "სამეცნიერო სტატია" @default.
• Q96121778 name "Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)" @default.
• Q96121778 name "Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)" @default.
• Q96121778 type Item @default.
• Q96121778 label "Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)" @default.
• Q96121778 label "Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)" @default.
• Q96121778 prefLabel "Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)" @default.
• Q96121778 prefLabel "Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)" @default.
• Q96121778 P1433 Q96121778-03BBB682-613D-4CE2-85E1-9B561BD81D23 @default.
• Q96121778 P1476 Q96121778-566A81AB-602D-4AD8-8861-173A0A00150C @default.
• Q96121778 P2093 Q96121778-18C0E63C-B709-46B5-A541-F99B6444C24B @default.
• Q96121778 P2093 Q96121778-1A724077-B63E-4A40-9583-CE9C6079C43E @default.
• Q96121778 P2093 Q96121778-2BE5A21E-0809-4388-B51B-58392A603462 @default.
• Q96121778 P2093 Q96121778-355E107F-1F25-4CF7-9694-9174FCB42CAE @default.
• Q96121778 P2093 Q96121778-3A857A0B-E463-49E6-A84B-207E28427CB0 @default.
• Q96121778 P2093 Q96121778-40311F88-E97A-4D0E-8065-5082D02D1C99 @default.
• Q96121778 P2093 Q96121778-458C3D5C-0A78-4C48-BFF4-9D670FEF4A8C @default.
• Q96121778 P2093 Q96121778-6267D471-7416-4B88-B9D4-375790B42BA8 @default.
• Q96121778 P2093 Q96121778-6FA7203E-015F-42A3-840C-BF40A04B02BC @default.
• Q96121778 P2093 Q96121778-8177C2AB-6872-49C4-88DE-5AD8467C46B7 @default.
• Q96121778 P2093 Q96121778-9FAB7B22-80DD-48E2-9C73-23B1CED6AEB0 @default.
• Q96121778 P2093 Q96121778-A05EA68F-041C-4774-B8C7-7D4BB716890B @default.
• Q96121778 P2093 Q96121778-A7A59DDD-3EE0-4CE7-8E83-2FEC2E3840A9 @default.
• Q96121778 P2093 Q96121778-C7A573E0-94F2-45B6-A330-ADDB200E4492 @default.
• Q96121778 P2093 Q96121778-EC4575A7-F617-4F4C-A6A9-FB35EA5FDB27 @default.
• Q96121778 P304 Q96121778-AABCAFD9-D718-4C05-B3CE-CAC2645F8F96 @default.
• Q96121778 P31 Q96121778-3A738649-1B61-41E2-AB47-0A051FFD8AA7 @default.
• Q96121778 P356 Q96121778-96FDB9F1-9AD6-4A1B-BEAE-33315D162051 @default.
• Q96121778 P433 Q96121778-2924515D-C057-49E1-A070-6D5CCD69683F @default.
• Q96121778 P478 Q96121778-BE6B5288-9300-47BC-89AD-2E100C4768C0 @default.
• Q96121778 P50 Q96121778-011CE11A-B1D3-482D-B49E-B901F937D1DD @default.
• Q96121778 P50 Q96121778-11C0967A-6428-42E2-8196-C07607D6E8F1 @default.
• Q96121778 P577 Q96121778-7D7F9ECE-3911-4759-8135-7B47C5E8F395 @default.
• Q96121778 P698 Q96121778-01897B9A-2BC6-4447-BB23-822221E0276D @default.
• Q96121778 P921 Q96121778-44F3061D-7005-4B94-BB1A-1B438292BB63 @default.
• Q96121778 P921 Q96121778-885F50A9-3E80-4610-8F2D-7036F1AF83A0 @default.
• Q96121778 P932 Q96121778-5AC886C7-7807-4A6E-BD05-7CA9AC67D2B3 @default.
• Q96121778 P356 S12885-020-06958-3 @default.
• Q96121778 P698 32487035 @default.
• Q96121778 P1433 Q326300 @default.
• Q96121778 P1476 "Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)" @default.
• Q96121778 P2093 "Albrecht Kretzschmar" @default.
• Q96121778 P2093 "Axel Hinke" @default.

• next